Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes
- PMID: 16584465
- PMCID: PMC1702507
- DOI: 10.1111/j.1475-6773.2005.00482.x
Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes
Abstract
Objective: To determine prevalence of chronic kidney disease (CKD) in patients with diabetes, and accuracy of International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes to identify such patients.
Data sources/study setting: Secondary data from 1999 to 2000. We linked all inpatient and outpatient administrative and clinical records of U.S. veterans with diabetes dually enrolled in Medicare and the Veterans Administration (VA) health care systems.
Study design: We used a cross-sectional, observational design to determine the sensitivity and specificity of renal-related ICD-9-CM diagnosis codes in identifying individuals with chronic kidney disease.
Data collection/extraction methods: We estimated glomerular filtration rate (eGFR) from serum creatinine and defined CKD as Stage 3, 4, or 5 CKD by eGFR criterion according to the Kidney Disease Outcomes Quality Initiative guidelines. Renal-related ICD-9-CM codes were grouped by algorithm.
Principal findings: Prevalence of CKD was 31.6 percent in the veteran sample with diabetes. Depending on the detail of the algorithm, only 20.2 to 42.4 percent of individuals with CKD received a renal-related diagnosis code in either VA or Medicare records over 1 year. Specificity of renal codes for CKD ranged from 93.2 to 99.4 percent. Patients hospitalized in VA facilities were slightly more likely to be correctly coded for CKD than patients hospitalized in facilities reimbursed by Medicare (OR 5.4 versus 4.1, p=.0330)
Conclusions: CKD is a common comorbidity for patients with diabetes in the VA system. Diagnosis codes in administrative records from Medicare and VA systems are insensitive, but specific markers for patients with CKD.
References
-
- AHA. Coding Clinic for ICD-9-CM: Official Guidelines for Coding and Reporting/American Hospital Association. Chicago: American Hospital Association; 2002.
-
- Anderson RJ, O'Brien M, MaWhinney S, VillaNueva CB, Moritz TE, Sethi GK, Henderson WG, Hammermeister KE, Grover FL, Shroyer AL. “Renal Failure Predisposes Patients to Adverse Outcome after Coronary Artery Bypass Surgery. VA Cooperative Study #5.”. Kidney International. 1999;55((3)):1057–62. - PubMed
-
- Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. “Risk of End-Stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT. Multiple Risk Factor Intervention Trial.”. Journal of the American Medical Association. 1997;278((23)):2069–74. - PubMed
-
- Brenner BM, Cooper ME, deZeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhan Z, Shahinfar S. “Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy.”. New England Journal of Medicine. 2001;345((12)):861–9. - PubMed
-
- Callahan M, Battleman DS, Christos P, Efimba M, Whitelaw G. “Economic Consequences of Renal Dysfunction among Cardiopulmonary Bypass Surgery Patients A Hospital-Based Perspective.”. Value Health. 2003;6((2)):137–43. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous